Histone H3R8me2s Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Histone H3R8me2s antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Histone H3R8me2s |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.1 mL, 0.2 mL |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB), Immunofluorescence (IF), Immunoprecipitation (IP), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Histone H3R8me2s antibody detects endogenous levels of total Histone H3R8me2s. Description: Modulation of chromatin structure plays an important role in the regulation of transcription in eukaryotes. The nucleosome, made up of DNA wound around eight core histone proteins (two each of H2A, H2B, H3, and H4), is the primary building block of chromatin (1). The amino-terminal tails of core histones undergo various post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination (2-5). These modifications occur in response to various stimuli and have a direct effect on the accessibility of chromatin to transcription factors and, therefore, gene expression (6). In most species, histone H2B is |
| Immunogen | Immunogen: A synthetic peptide derived from human Histone H3R8me2s |
| Other Names | [histone H3.1t; Histone H3.1t; histone H3.1t; histone cluster 3 H3; H3/g] |
| Gene, Accession # | [HIST3H3], Gene ID: 8290, NCBI: NP_003484.1, UniProt: Q16695 |
| Catalog # | MBS9607605 |
| Price | $240, $280 |
| Order / More Info | Histone H3R8me2s Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies